AI has ‘untapped potential’ for entrepreneurs

Subrata Thakar | | Health Exec | Economics

AI applications in healthcare are just ramping up, allowing for an influx of entrepreneurs, according to a new report from Entrepreneur.

“This technology stands on the cusp, ready to improve nearly every industry; and it offers a myriad of opportunities for entrepreneurs able to imagine and execute new applications for the future,” wrote guest writer Brian Hughes, CEO of Integrity Marketing & Consulting.

The healthcare-focused AI market is expected to grow into a $36.1 billion industry, which translates to 50 percent growth through 2025. Financing for AI-based technologies is also increasing, as AI is already used in a variety of clinical settings—and frequently in imaging. But Hughes noted there is “untapped potential” which could bring “a wealth of opportunities” specific to entrepreneurs. 

“From research to diagnosis and treatment, the AI applications in healthcare have barely scratched the surface, leaving a wide field for entrepreneurs to enter,” Hughes said.

To read the story, click the link below.

AI Opportunities Abound, If You Know the Unexpected Places to Look

""
Subrata Thakar

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Related Content

Walgreens $10B private equity buyout financed by 83% debt
Walgreens confirms $10B sale to PE, as part of $24B transaction
5 ways AI can help make healthcare more affordable for everyone
More than 1,000 hospitals earn $700M opioid crisis judgment
Building a successful CCTA program: Physicians and healthcare executives to share advice
VA planning 83,000 layoffs as part of restructuring

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.